Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson's Disease: Meta-Analysis of Randomized Controlled Trials

Author： Kulisevsky Jaime   Pagonabarraga Javier  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.33, Iss.2, 2010-02, pp. : 147-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson's Disease: A Meta-Analysis of Randomised Controlled Trials

By Etminan M.  

Drug Safety, Vol. 24, Iss. 11, 2001-01 ,pp. : 863-868

Adis International

Access to resources Recommend Favorite

Cost Analysis of Ropinirole versus Levodopa in the Treatment of Parkinson's Disease

By Iskedjian M.  

PharmacoEconomics, Vol. 21, Iss. 2, 2003-01 ,pp. : 115-127

Adis International

Access to resources Recommend Favorite

The safety of dopamine agonists in the treatment of Parkinson's disease

By Bonuccelli Ubaldo   Ceravolo Roberto  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 111-127

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials

By Liu Lin-Lin  

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1521-1533

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism

By  

Current Pharmaceutical Design, Vol. 11, Iss. 30, 2005-11 ,pp. : 3893-3918

Bentham Science Publishers

Access to resources Recommend Favorite